It's necessary to get Adobe Flash Player to see this page correctly.
| NEWS | BIOGRAPHIES | EVENTS | INSIDE FIS | MARKETING | MEDICAL | |
OLYMPIC
CROSS-COUNTRY
SKI JUMPING
NORDIC COMBINED
ALPINE SKIING
FREESTYLE SKIING
SNOWBOARD
OTHERS
SPEED SKIING
GRASS SKIING
TELEMARK
MASTERS
CALENDAR
RESULTS
STATISTICS
LIVE TIMING
FIS HISTORY
CROSS-COUNTRY
SKI JUMPING
NORDIC COMBINED
ALPINE SKIING
FREESTYLE SKIING
SNOWBOARD
OTHERS
SPEED SKIING
GRASS SKIING
TELEMARK
MASTERS
CALENDAR
RESULTS
STATISTICS
LIVE TIMING
FIS HISTORY
| FIS Anti-Doping >> Medical / Anti-Doping Rules >> Therapeutic Use Exemptions (TUE) |
Information
Athletes included in the FIS International Registered Testing Pool need to obtain aTUE approval from FIS.
(TUE approvals issued by NADOs are accepted for all other athletes, ergo non-FIS RTP athletes).
Therapeutic Use Exemptions (TUE)
WADA International Standard for Therapeutic Use Exemption 2011
FIS Therapeutic Use Exemptions form (to be completed electronically)
Requirements for use of the beta-2-agonists formoterol and terbutaline
Current FIS/IOC Anti-Doping requirements for use of the beta-2 agonists formoterol and terbutaline
For any questions please contact FIS Anti-Doping antidoping@fisski.com